Guidehealth

Based in the US, Guidehealth provides an advanced technology platform that utilizes artificial intelligence to enhance patient care by predicting health needs proactively. Their solutions aim to improve health outcomes and streamline care processes for healthcare providers. Founded in 2023 and headquartered in Dallas, US, Guidehealth specializes in AI-driven healthcare solutions that support proactive patient engagement. The company raised USD 14.

000 mn in Seed funding on August 6, 2024, led by Memorial Hermann Health System Foundation, with the total amount raised to date also at USD 14. 000 mn. The team's strategic focus is on utilizing this funding to further develop their technology and managed services organization (MSO). Guidehealth provides an integrated technology platform designed to enhance patient care through personalized artificial intelligence (AI) solutions.

Their core offerings include a Virtual Healthguide system that leverages Large Language Models (LLMs) and generative AI to predict patient care needs before preventable health events occur. This system serves as an extension of primary care providers (PCPs), facilitating proactive engagement with patients and their families to monitor care statuses and streamline multi-provider care plans. The aim is to improve health outcomes and operational efficiency, thereby supporting complex patients and their families. Guidehealth primarily operates in the United States, serving a diverse client base that includes healthcare providers, health systems, and ultimately the patients within their networks.

Guidehealth generates revenue through partnerships and subscriptions to its technology platform, which allows healthcare organizations to adopt its AI-driven solutions. The company's business model is structured around long-term contracts with healthcare providers and systems that integrate Guidehealth’s services into their existing workflows. Transactions typically involve subscription fees for access to the platform, with varying pricing plans tailored to the size and needs of the client organization. These plans may include features based on the volume of patients served or the specific functionalities utilized, such as monitoring capabilities and data aggregation services.

Guidehealth’s flagship product, the Healthguide, is central to these transactions and is aimed at enhancing value-based care delivery and improving patient engagement outcomes. The company plans to develop new products aimed at further advancing patient care technology and is targeting expansion into additional geographic regions, although specific markets have yet to be disclosed. In June 2025, Guidehealth raised USD 10 million in venture funding from Emory University Endowment. The company plans to utilize the June 2025 funding to expansion of artificial intelligence-powered healthcare platform and enhancement of chronic disease management.